Info@ThinkPinkRocks.com

PDL BioPharma receives $30.3M to conclude revenue interest contract with AxoGen

PDL BioPharma, Inc. (PDL) today announced that the company has received $30.3 million, in addition to previously received revenue interest payments, to conclude PDL’s revenue interest agreement with AxoGen, Inc.

Original post:
PDL BioPharma receives $30.3M to conclude revenue interest contract with AxoGen

Share
1 Comment
  1. Hi evеryone, it’s my first pay a visit at this site, and paragraph
    is genuinely fruitful for me, keep up posting these articles ᧐r reviews.

Leave a Reply

Solve : *
3 + 22 =